» Authors » Hla-Hla Thein

Hla-Hla Thein

Explore the profile of Hla-Hla Thein including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 38
Citations 924
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Wong W, Haines A, Bremner K, Yao Z, Calzavara A, Mitsakakis N, et al.
CMAJ Open . 2021 Mar; 9(1):E167-E174. PMID: 33688024
Background: High-quality estimates of health care costs are required to understand the burden of illness and to inform economic models. We estimated the costs associated with hepatitis C virus (HCV)...
2.
Kwon J, Chambers G, Luciani F, Zhang L, Kinathil S, Kim D, et al.
PLoS One . 2021 Feb; 16(2):e0245896. PMID: 33571196
In Australian prisons approximately 20% of inmates are chronically infected with hepatitis C virus (HCV), providing an important population for targeted treatment and prevention. A dynamic mathematical model of HCV...
3.
Hamadeh A, Haines A, Feng Z, Thein H, Janjua N, Krahn M, et al.
J Viral Hepat . 2020 Aug; 27(12):1419-1429. PMID: 32810886
Patients identified as having chronic hepatitis C (CHC) infection can be effectively and rapidly treated using direct-acting antiviral agents. However, there remains a substantial burden of subclinical undetected infection. This...
4.
Erman A, Krahn M, Hansen T, Wong J, Bielecki J, Feld J, et al.
BMJ Open . 2019 Nov; 9(11):e027491. PMID: 31719068
Objectives: Mathematical models are increasingly important in planning for the upcoming chronic hepatitis C (CHC) elimination efforts. Such models require reliable natural history inputs to make accurate predictions on health...
5.
Sahakyan Y, Wong W, Yi Q, Thein H, Tomlinson G, Krahn M
J Viral Hepat . 2019 Oct; 27(3):235-242. PMID: 31654536
The Federal Government of Canada established a $1.1 billion compensation programme in 1999 to support individuals who acquired hepatitis C virus (HCV) through blood products between January 1986 and July...
6.
Thein H, Jembere N, Thavorn K, Chan K, Coyte P, de Oliveira C, et al.
BMC Cancer . 2018 Jun; 18(1):694. PMID: 29945563
Background: Esophageal adenocarcinoma (EAC) incidence is increasing rapidly. Esophageal cancer has the second lowest 5-year survival rate of people diagnosed with cancer in Canada. Given the poor survival and the...
7.
Thein H, Anyiwe K, Jembere N, Yu B, De P, Earle C
PLoS One . 2017 Oct; 12(10):e0186350. PMID: 29020052
The incidence of esophageal adenocarcinoma (EAC) is increasing worldwide and has overtaken squamous histology in occurrence. We studied the impact of socioeconomic status (SES) on EAC stage at diagnosis, receipt...
8.
Thein H, Qiao Y, Zaheen A, Jembere N, Sapisochin G, Chan K, et al.
PLoS One . 2017 Oct; 12(10):e0185198. PMID: 29016627
Hepatocellular carcinoma (HCC) presentation is heterogeneous necessitating a variety of therapeutic interventions with varying efficacies and associated prognoses. Poor prognostic patients often undergo non-curative palliative interventions including transarterial chemoembolization (TACE),...
9.
Thein H, Isaranuwatchai W, Qiao Y, Wong K, Sapisochin G, Chan K, et al.
Cancer Med . 2017 Aug; 6(9):2017-2033. PMID: 28791798
Patients with early-stage hepatocellular carcinoma (HCC) are potential candidates for curative treatments such as radiofrequency ablation (RFA), surgical resection (SR), or liver transplantation (LT), which have demonstrated a significant survival...
10.
Aravinthan A, Bruni S, Doyle A, Thein H, Goldaracena N, Issachar A, et al.
Ann Surg Oncol . 2017 Feb; 24(7):1843-1851. PMID: 28160137
Background: Patients with hepatocellular carcinoma (HCC) beyond the traditional criteria (advanced HCC) are typically offered palliation, which is associated with a 3-year survival rate lower than 30%. This study aimed...